MetLife (MET) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
8 Jan, 2026Executive summary
Delivered strong Q4 and full-year 2024 results, exceeding all five-year strategic and Next Horizon financial commitments despite macroeconomic volatility and industry challenges.
Launched New Frontier strategy focused on responsible growth, with four strategic priorities: Group Benefits, retirement platform, asset management, and international expansion.
Net income for 2024 was $4.2B, up from $1.4B in 2023; adjusted earnings reached $5.8B, up 5% year-over-year; adjusted EPS increased 12% to $8.15.
Book value per share declined 4% to $34.28, while adjusted book value per share rose 2% to $54.81.
Announced key transactions: formation of Chariot Re, acquisition of PineBridge Investments, and purchase of Mesirow Financial teams to enhance asset management capabilities.
Financial highlights
Q4 2024 adjusted earnings: $1.5B ($2.09/share), up 14% year-over-year; adjusted EPS excluding notable items: $2.08, up 8%.
Full-year 2024 adjusted earnings (excluding notable items): $5.8B; adjusted ROE: 15.2%, above target; direct expense ratio: 12.1%, below target.
Net income: $1.2B in Q4 and $4.2B for full year, with derivative losses offset by market risk-benefit gains.
Premiums, fees, and other revenues for 2024 were $52.5B, up 1% year-over-year; net investment income for 2024 was $21.3B, up 7%.
Returned $4.7B to shareholders in 2024 ($3.2B buybacks, $1.5B dividends); $470M repurchased in January 2025.
Outlook and guidance
Targeting double-digit adjusted EPS growth and adjusted ROE of 15%-17% for 2025.
Free cash flow commitment raised to $25B over five years; direct expense ratio guidance lowered to 12.1% for 2025.
Variable investment income expected at $1.7B pre-tax in 2025; private equity and real estate returns forecasted to improve.
Group Benefits PFO growth target increased to 4%-7% annually; RIS liability growth guidance raised to 3%-5%.
Asia and Latin America expected to see mid- to high-single digit growth on a constant currency basis, with currency headwinds impacting reported results.
Latest events from MetLife
- Scale, technology, and disciplined growth drive strong earnings and market leadership.MET
47th Annual Raymond James Institutional Investor Conference4 Mar 2026 - New Frontier strategy delivers growth, efficiency, and global expansion, targeting double-digit EPS.MET
Bank of America Financial Services Conference 202610 Feb 2026 - Adjusted EPS up 10%, 16% ROE, and record AUM after major acquisition.MET
Q4 20255 Feb 2026 - Board, compensation, and auditor proposals passed; racial equity audit proposal rejected.MET
AGM 20243 Feb 2026 - Net income surged 146% with adjusted earnings up 9% and record Group Benefits results.MET
Q2 20242 Feb 2026 - Surpassed strategic goals and set sights on accelerated growth with the New Frontier plan.MET
2024 KBW Insurance Conference22 Jan 2026 - Net income jumped to $1.3B, but adjusted earnings declined 8% year-over-year.MET
Q3 202417 Jan 2026 - New Frontier targets double-digit EPS growth and 15–17% ROE, leveraging scale and global expansion.MET
Investor Day 202411 Jan 2026 - New Frontier targets higher growth, stable margins, and global expansion with disciplined M&A.MET
Bank of America Securities Financial Services Conference8 Jan 2026